BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Apr 25, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

PRT-201: Phase II started

Proteon began a double-blind, placebo-controlled Phase II trial to evaluate 10 and 30 µg PRT-201 administered immediately after AVF creation in about 150 patients with chronic kidney disease (CKD).

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >